| #327 |
John Goeltz |
Lockheed Martin |
2 |
| #327 |
Sung-Yon Kim |
MIT |
2 |
| #327 |
Devin Scott Quinlan |
Renagade Therapeutics Management |
2 |
| #327 |
Li Zhao |
Beth Israel Deaconess Medical Center |
2 |
| #327 |
Davide Sosso |
Inari Agriculture Technology |
2 |
| #327 |
Samson J. Timoner |
Scalable Display Technologies |
2 |
| #327 |
Alim Ladha |
MIT |
2 |
| #327 |
Samuel T. Reineman |
Space Exploration Technologies |
2 |
| #327 |
Kenneth Knute Leidal |
Pathai |
2 |
| #327 |
Christopher Rohde |
Factor Bioscience |
2 |
| #327 |
David P. Corey |
Harvard University |
2 |
| #327 |
Robert Eugene Paolini |
Boston Dynamics |
2 |
| #327 |
Omar Khan |
MIT |
2 |
| #327 |
Dinara GUNASEKERA |
Flagship Pioneering Innovations Vi |
2 |
| #327 |
Jason D. Brubaker |
Merck |
2 |
| #327 |
Deep Arjun Singh |
Alcyone Lifesciences |
2 |
| #327 |
Amy J. Wagers |
Harvard University |
2 |
| #327 |
Xirui Hu |
Bristol-Myers Squibb |
2 |
| #327 |
Schendy G. Kernizan |
MIT |
2 |
| #327 |
Orhun K. Muratoglu |
The General Hospital |
2 |
| #327 |
Zhe Shi |
MIT |
2 |
| #327 |
Sabine K. Ruppel |
Foghorn Therapeutics |
2 |
| #327 |
David B. MacLean |
Pfizer |
2 |
| #327 |
Nannaji Saka |
Unknown |
2 |
| #327 |
Thomas M. Barnes |
Orna Therapeutics |
2 |
| #327 |
Joseph Michael Sanchez, JR. |
— |
2 |
| #327 |
Sayda M. Elbashir |
Modernatx |
2 |
| #327 |
Pralay Senchaudhuri |
Cytel |
2 |
| #327 |
Cyrus Mehta |
Cytel |
2 |
| #327 |
Kevin Michael Esvelt |
Harvard University |
2 |
| #681 |
Stephane Bancel |
Modernatx |
1 |
| #681 |
Karthish Manthiram |
Carnegie Mellon University |
1 |
| #681 |
Mirko Ristivojevic |
Amazon |
1 |
| #681 |
Justin Klee |
Amylyx Pharmaceuticals |
1 |
| #681 |
Neena Kenton Pyzocha |
Inari Agriculture Technology |
1 |
| #681 |
Joshua Close |
Merck |
1 |
| #681 |
Evelyn N. Wang |
MIT |
1 |
| #681 |
Sally A. Miller |
Agri-Diagnostics Associates |
1 |
| #681 |
Hanrui Wang |
NVIDIA |
1 |
| #681 |
Mitchell H. Finer |
Cell Genesys |
1 |
| #681 |
Akiko Noma |
Bayer Healthcare |
1 |
| #681 |
Ananda Wickramasekera |
— |
1 |
| #681 |
Donald Johns |
Novartis Ag |
1 |
| #681 |
Hao-Wei Su |
Google |
1 |
| #681 |
Aleksey Shaporev |
Google |
1 |
| #681 |
Ahmed Helal |
MIT |
1 |
| #681 |
Colin Gounden |
Via Science |
1 |
| #681 |
Emilio Alvarez Flores |
— |
1 |
| #681 |
William Kissel |
Cyclerion Therapeutics |
1 |
| #681 |
Rebecca ARON |
Johnson & Johnson |
1 |